Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia
Background: In Colombia, hemophilia is considered a high-cost disease, and hemophilia A with high-titer inhibitors may be responsible for a significant economic pressure on the Colombian health system. Objectives: To estimate the direct cost of care for patients with hemophilia A with high-titer i...
Saved in:
Institution: | FUCS -Fundación Universitaria de Ciencias de la Salud |
---|---|
Main Authors: | , , , , , |
Format: | Artículo de revista |
Language: | English |
Published: |
Elsevier
2019
|
Subjects: | |
Online Access: | https://repositorio.fucsalud.edu.co/handle/001/3164 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|